awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q26824310-37B668FE-081C-4867-95C0-9FCBA2F356C9
Q26824310-37B668FE-081C-4867-95C0-9FCBA2F356C9
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26824310-37B668FE-081C-4867-95C0-9FCBA2F356C9
Ipilimumab, vemurafenib, dabrafenib, and trametinib: synergistic competitors in the clinical management of BRAF mutant malignant melanoma
P2860
Q26824310-37B668FE-081C-4867-95C0-9FCBA2F356C9
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26824310-37B668FE-081C-4867-95C0-9FCBA2F356C9
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
f063966b7f3043d11e45825c8715cacff025d62d
P2860
Tumour micro-environment elicits innate resistance to RAF inhibitors through HGF secretion